Citius Pharmaceuticals- Warrants(02/08/2022) Other Current Liabilities

As of the most recent data (June 2026), CTXRW shows a other current liabilities of $43M. That compares with $42M in the prior-year period — up 4.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CTXRW's other current liabilities is now $43M (was $42M) — a 4.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Citius Pharmaceuticals- Warrants(02/08/2022) is outperforming or lagging.

Tracking CTXRW's other current liabilities over time shows whether Citius Pharmaceuticals- Warrants(02/08/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $43M That compares with $42M in the prior-year period — up 4.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Citius Pharmaceuticals- Warrants(02/08/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $43M) with ownership activity and broader fundamentals.

Citius Pharmaceuticals- Warrants(02/08/2022)'s other current liabilities is $43M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.